Zoetis
Vanguard CIV Canine Influenza Vaccine (H3N2), Killed Virus
Vanguard CIV Canine Influenza Vaccine (H3N2), Killed Virus
Low stock: 6 left
This is the TOTAL number of inventory that is currently in stock, including BOGO availability. If you would like to purchase the full amount or more, your delivery time may be delayed.
For vaccination of healthy dogs 8 weeks of age or older against canine influenza (H3N2) virus infection. This product contains the canine influenza strains A/Illinois/12191/2015 (H3N2).
CIV vaccines do not cross-protect against the two known circulating strains in the United States. Zoetis strongly recommends that these vaccines be used only used if a dog is lacking vaccination against one of the two strains, and then continue with the use of Vanguard CIV H3N2/H3N8.
- Canine immune response to CIV can be severe and result in suppurative pneumonia and cell death.1-3 Vaccination can help prevent coinfections and worsening clinical morbidity as well as prevent or reduce subclinical lung lesions.4-6
- Killed vaccine – cannot transmit CIV because it is unable to replicate to cause disease; therefore safe for administration around immunocompromised pet owners/veterinary staff.
Healthy dogs should receive 2 doses administered 3 weeks apart. Historically, annual
revaccination with this product was recommended. The need for annual booster
vaccinations has not been established for this product; consultation with a veterinarian or the manufacturer is recommended.
WARNING: This product has not been tested in pregnant animals. In case of anaphylactoid reaction, administer epinephrine. Do not mix with other products. In case of human exposure, contact a physician.
